Sensory effects of antimuscarinics: still a matter of debate.

Suppr

超能文献

作者信息

Behr-Roussel Delphine, Giuliano François A

出版信息

Eur Urol. 2010 Jul;58(1):29-30. doi: 10.1016/j.eururo.2010.01.010. Epub 2010 Jan 18.

DOI:10.1016/j.eururo.2010.01.010

PMID:20083339

Abstract

摘要

相似文献

Sensory effects of antimuscarinics: still a matter of debate.

Eur Urol. 2010 Jul;58(1):29-30. doi: 10.1016/j.eururo.2010.01.010. Epub 2010 Jan 18.

Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.

Eur Urol. 2008 Jul;54(1):226-30. doi: 10.1016/j.eururo.2008.04.020. Epub 2008 Apr 16.

Better management of patients with overactive bladder with antimuscarinics?

Int J Clin Pract. 2008 Jan;62(1):3-4. doi: 10.1111/j.1742-1241.2007.01627.x.

Antimuscarinics and overactive bladder: other mechanism of action.

Neurourol Urodyn. 2010;29(1):112-5. doi: 10.1002/nau.20796.

Preclinical compounds for the treatment of overactive bladder.

Expert Opin Ther Pat. 2009 Feb;19(2):107-17. doi: 10.1517/13543770802672606.

Local effects of antimuscarinics.

Urol Clin North Am. 2006 Nov;33(4):511-8, ix-x. doi: 10.1016/j.ucl.2006.06.011.

Muscarinic receptor antagonists for overactive bladder.

BJU Int. 2007 Nov;100(5):987-1006. doi: 10.1111/j.1464-410X.2007.07205.x.

Re: Treating patients with overactive bladder symptoms with antimuscarinics; heart rate considerations.

BJU Int. 2008 Jan;101(1):129. doi: 10.1111/j.1464-410X.2007.07380_3.x.

Antimuscarinics and cognitive function.

Eur Urol. 2006 Aug;50(2):211-2. doi: 10.1016/j.eururo.2006.03.060. Epub 2006 Apr 19.

Fesoterodine (toviaz) for overactive bladder.

Med Lett Drugs Ther. 2009 May 4;51(1311):34-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Sensory effects of antimuscarinics: still a matter of debate.

Eur Urol. 2010 Jul;58(1):29-30. doi: 10.1016/j.eururo.2010.01.010. Epub 2010 Jan 18.

Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.

Eur Urol. 2008 Jul;54(1):226-30. doi: 10.1016/j.eururo.2008.04.020. Epub 2008 Apr 16.

Better management of patients with overactive bladder with antimuscarinics?

Int J Clin Pract. 2008 Jan;62(1):3-4. doi: 10.1111/j.1742-1241.2007.01627.x.

Antimuscarinics and overactive bladder: other mechanism of action.

Neurourol Urodyn. 2010;29(1):112-5. doi: 10.1002/nau.20796.

Preclinical compounds for the treatment of overactive bladder.

Expert Opin Ther Pat. 2009 Feb;19(2):107-17. doi: 10.1517/13543770802672606.

Local effects of antimuscarinics.

Urol Clin North Am. 2006 Nov;33(4):511-8, ix-x. doi: 10.1016/j.ucl.2006.06.011.

Muscarinic receptor antagonists for overactive bladder.

BJU Int. 2007 Nov;100(5):987-1006. doi: 10.1111/j.1464-410X.2007.07205.x.

Re: Treating patients with overactive bladder symptoms with antimuscarinics; heart rate considerations.

BJU Int. 2008 Jan;101(1):129. doi: 10.1111/j.1464-410X.2007.07380_3.x.

Antimuscarinics and cognitive function.

Eur Urol. 2006 Aug;50(2):211-2. doi: 10.1016/j.eururo.2006.03.060. Epub 2006 Apr 19.

Fesoterodine (toviaz) for overactive bladder.

Med Lett Drugs Ther. 2009 May 4;51(1311):34-5.